A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2+ Solid Cancer
Article
Hombach, Andreas A., Ambrose, Christine, Lobb, Roy, Rennert, Paul and Abken, Hinrich (2023) A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2+ Solid Cancer. Cells 12 (2), p. 248.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cells | ||||
| Publisher | MDPI | ||||
| Place of Publication | BASEL | ||||
| Volume | 12 | ||||
| Number of Issue or Book Chapter | 2 | ||||
| Page Range | p. 248 | ||||
| Date | 2023 | ||||
| Date of publication | 18 Mar 2025 10:07 | ||||
| Institutions | Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | THERAPY; IMMUNORECEPTORS; COSTIMULATION; ACTIVATION; LYMPHOMA; chimeric antigen receptor; ErbB2 (Her2; neu); herceptin; scFv fusion protein; CD19 | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 75939 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric